Background: Recurrent pyogenic cholangitis (RPC) is still a common disease in East Asia. The present
Introduction
Recurrent pyogenic cholangitis (RPC) is a peculiar disease entity commonly found in East Asia. [1] [2] [3] [4] It is a progressive biliary disease that involves diffuse biliary tract ectasia and primary stone formation. Morphologically, it is characterized by pigmented ductal stone and ductal stricture (intrahepatic and/or extrahepatic), cisternal dilatation of the proximal ducts, hepatic segmental or lobar atrophy, thrombosis of the portal vein tributaries, superimposed cholangiocarcinoma and biliary cirrhosis. Patients usually present with repeated episodes of bacterial cholangitis. Some patients may present with acute pancreatitis, liver abscess or abdominal pain. Management of RPC is difficult because of the presence of deepseated intrahepatic ductal stones and ductal strictures, which are often multiple. Endoscopic therapy in terms of biliary stenting, stone retrieval and stricture dilatation is useful in emergency situations or as a temporary measure. Surgical treatment remains the definitive and radical treatment for RPC to prevent stone formation and recurrent attacks of cholangitis.
Materials and methods
We performed a retrospective review of 85 patients with RPC who received surgical treatment from August 1995 to March 2008 in the Department of Surgery, Prince of Wales Hospital, Chinese University of Hong Kong. The diagnosis of RPC was based on clinical and radiological findings (Fig. 1) . [5] [6] [7] Histological confirmation was available for 64 patients who had undergone hepatectomy. Demographic data, investigation results, operative findings and follow-up details were analysed. We focused on the documentation of residual and recurrent stone, recurrent cholangitis and the development of cholangiocarcinoma.
Residual stone was defined as incomplete stone clearance as revealed during surgery by intraoperative ultrasound or cholangiography, or by imaging results obtained within 3 months of surgery. The time interval of 3 months was chosen according to a recent study by Lee et al. 8 Recurrent stone was defined as new stone formation as shown on imaging or endoscopic retrograde cholangiopancreatography (ERCP) >3 months after initial complete clearance by operation. Survival was calculated using the Kaplan-Meier method.
Choices of surgical treatment
In general, surgical treatment was offered if the patient suffered repeated cholangitic attacks as a result of RPC. Treatment options included liver resection, biliary drainage alone, combined liver resection and biliary drainage, and percutaneous choledochoscopy. The choice of therapy was decided according to the patient's condition, such as fitness for general anaesthesia, tolerance for hepatectomy, previous treatment failure, multiple previous operations and local anatomical factors. Liver resection was considered for atrophic liver lobe or segment, lobe-or segment-predominant disease, or suspected cholangiocarcinoma. Drainage procedures were indicated for main duct stricture, grossly dilated common duct with bile stasis problems or if common bile duct stones recurred. Biliary drainage was usually performed as a hepaticojejunostomy with or without the creation of an access loop to facilitate the subsequent retrieval of recurrent stones. Other less commonly used drainage procedures included transduodenal sphincteroplasty or T-tube drainage. If patients were unfit for general anaesthesia, percutaneous choledochoscopic removal of stones or fragmentation of stones could be performed under local anaesthesia after serial dilatation of the percutaneous transhepatic biliary tract. Tract choledochoscopy was the preferred option when a patient had recurrent stones after previous hepatectomy or drainage procedures. Except for cases undergoing percutaneous choledochoscopy, cholecystectomy would be performed during surgery for concurrent gallstones or for the prevention of subsequent cholelithiasis. The clearance of the common bile duct would also be confirmed by exploration through the ductal opening at the transected liver surface or direct choledochotomy.
Results
The study included 35 men and 50 women with a median age of 61 years (range 27-85 years). The initial presenting features of the patients were as follows: acute cholangitis (50.6%); abdominal pain (32.9%); jaundice (8.2%); acute pancreatitis (3.5%); liver abscess (3.5%), and incidental findings (1.2%). The median duration of RPC was 24 months, but one patient was known to have had the disease for 34 years. A total of 37 patients (43.5%) had undergone previous biliary surgery, of whom eight had undergone two previous operations and two had undergone three. Types of previous operations are shown in Table 1 . All except six patients had ERCP before the index surgery. The average number of ERCP procedures performed before surgery was 2.8. One patient had undergone 10 ERCPs before surgery. By contrast, 28 patients (32.9%) had undergone percutaneous transhepatic biliary drain (PTBD) insertion before surgery.
Disease distribution in the liver lobes was recorded in 82 patients. In the majority of patients, disease was confined to the left liver lobe (64.6%). Only 4.9% of patients had isolated right lobe RPC. Bilobar involvement occurred in 30.5% of patients. Atrophic liver segments or lobe occurred in 49 (64.5%) of 76 patients. Major ductal strictures occurred in 41 (51.3%) of 80 patients. Gallstones were found in 43.9% of patients who had no previous cholecystectomy, whereas common bile duct stones were found in 27.2% patients who had no previous bile duct resection. Excluding cholecystectomy and exploration of the bile duct, which may constitute parts of the operations, the types of operative procedures performed are shown in Table 2 . There was no in-hospital or 30-day mortality. Forty-six complications Table 4 . Positive culture results were also obtained from infected wounds, drained fluid, pleural fluid or bile leak after surgery in 30 patients; organisms found are shown in Table 4 .
Histological results were available in 64 patients who underwent hepatectomy. All of them showed features of RPC. Four patients also had background liver cirrhosis. Three patients were found to have clonorchis sinesis infestation. Five patients had histological evidence of cholangiocarcinoma. Two of these five patients were diagnosed with cholangiocarcinoma before surgery and the other three were diagnosed after surgery. These 85 patients were followed for a median period of 45.4 months (range 2.6 months to 12.7 years). The 5-year survival was 87.3%. Eleven patients died during this period. Causes of death were cholangiocarcinoma in three patients and other malignant diseases in six patients. Of the remaining two patients, one died of cirrhosis and the other committed suicide. Three of the five cholangiocarcinoma patients had recurrent disease during the follow-up period and two of them died of the disease. One additional case of cholangiocarcinoma was diagnosed 2 years after surgery and died subsequently. All six cases of cholangiocarcinoma occurred in the group that underwent hepatectomy with or without a drainage procedure.
Overall, residual stones occurred in 18 patients (21.2%) and a further 14 patients (16.5%) developed recurrent stones after initial complete clearance. Fourteen patients had recurrent cholangitis and four patients had liver abscess during follow-up (Table 5) . No patient died of biliary sepsis. The group that underwent percutaneous choledochoscopy had the lowest rate of stone clearance (55.6%), and the group that underwent a drainage procedure alone carried the highest rates of stone recurrence (50.0%) and recurrent biliary sepsis (83.3%). Both the hepatectomy-alone group and the hepatectomy-plus-drainage-procedure group had high stone clearance rates (85.7% and 75.0%, respectively) and low stone recurrence rates (8.9% and 0%, respectively). Further combined analysis of these two groups of hepatectomy patients (n = 64), regardless of whether they underwent a concomitant drainage procedure, showed rates for stone clearance, stone recurrence and biliary sepsis recurrence to be 84.4%, 7.8% and 9.4%, respectively, over a median follow-up period of 42.7 months. The morbidity rate was 42.2%. The proportion of bilobar involvement of disease was 26.6% in this group of patients (Table 6 ).
Discussion
Recurrent pyogenic cholangitis is also commonly known as hepatolithiasis or intrahepatic stones. We prefer to describe the disease as RPC because it can involve the extrahepatic duct and gallbladder. In this study, 27.2% of patients had common bile duct stones and 43.9% patients had gallstones. However, the term 'hepatolithiasis' implies the presence of stones in intrahepatic ducts, which is also a feature of other diseases such as primary sclerosing cholangitis (PSC), postoperative stricture or malignant disease. The term 'recurrent pyogenic cholangitis' was first used by Cook et al. as early as 1954, although the disease was first described by Digby in 1930. 1, 2 It is prevalent in East Asians and Latin Americans, in lower socioeconomic groups and in people who live in rural environments. There is no gender difference in incidence of the disease and the peak incidence occurs in the third to fourth decades of life. 3 The incidence of RPC is declining in East Asia, but it is increasing in the West as a result of immigration. 9 A nationwide survey carried out in Japan in the 1970s revealed that RPC accounted for 4.1% of patients with biliary calculi who underwent surgery. 10 Recurrent pyogenic cholangitis is characterized by repeated primary infection of the biliary system by pus-forming bacteria and the development of pigmented stones and ductal strictures. The formation of stones is thought to result from the action of bacterial b-glucuronidase on conjugated bilirubin. 3 The organisms are enteric in origin and gain access to the liver through the portal vein.
During an acute attack of cholangitis, the management of RPC is similar to that of cholangitis secondary to gallstone. The primary aim is to control sepsis with antibiotics and biliary drainage. The PTBD procedure may be used more frequently if there is obstruction at the intrahepatic level. The definitive treatment of RPC aims to remove all stones, correct anatomical abnormalities or the source of infections, prevent recurrent attacks of cholangitis and stop the progression of the disease, which can lead to biliary cirrhosis. Various surgical options can be adopted according to disease distribution, the location of significant strictures, the presence of liver atrophy and the presence of suspected superimposed cholangiocarcinoma. Other factors also affect the choice of treatment as many patients have a longstanding history of disease(s) and may have undergone multiple ERCPs and previous surgery. However, we recommend that the gallbladder is removed and the common bile duct cleared at the time of surgery because co-existing gallstones and common bile duct stones occur in 43.9% and 27.2% of patients, respectively. Even in the absence of gallstones, prophylactic cholecystectomy will eliminate the need for a potentially difficult second operation if subsequent cholelithiasis or cholecystitis occurs. We adopted different treatment approaches for different patients, with satisfactory results. No surgery-related deaths occurred. Complications occurred in 40% of patients, half of which were wound infections. It was not surprising that infective complications occurred so frequently because 92.2% of preoperative or intraoperative bile culture results were positive. Hence it is important to give appropriate prophylactic antibiotics according to culture result as the organisms identified from infected sites after surgery were quite similar (Table 4 ). In order to reduce the rate of wound infection, we routinely packed the wound with saline gauze after surgery and left it to heal by secondary intention. The median blood loss (350 ml) and blood transfusion rate (16.5%) were acceptable and patients were able to be discharged after a median postoperative hospital stay of 12 days.
Overall rates for residual stones, stone recurrence and biliary sepsis recurrence were 21.2%, 16.5% and 21.2%, respectively, during follow-up. As Table 5 shows, the hepatectomy group achieved the most favourable results, whereas both the drainagealone and the percutaneous choledochoscopy groups performed badly in these three parameters. Hepaticojejunostomy and T-tube drainage were shown to have high residual stone rates (25.9%) and postoperative cholangitis (24%) in one recent retrospective study. 11 Another study comparing four different treatment approaches for hepatolithiasis also showed that hepatectomy achieved a better result than hepaticojejunostomy, T-tube drainage and percutaneous choledochoscopy. 12 If we combine the hepatectomy group of patients with the hepatectomy-plus-drainage-procedure group, the total number of patients who received hepatectomy for RPC amounts to 64. Outcomes for these 64 patients are compared with outcomes in recent series of hepatectomy for RPC in Table 6 . 8, [12] [13] [14] [15] [16] Mortality and morbidity rates and the incidence of cholangiocarcinoma in this study are similar to those in other series. Although we achieved the lowest stone clearance rate of 84.4%, our rates for stone and biliary sepsis recurrence are comparable with those in other series. This implies that although more stones were retained after surgery, such stone retention may not translate to a higher incidence of clinical problems as manifested by cholangitis or liver abscess during follow-up. The high rate of residual stones in our series may reflect the higher proportion of bilobar disease in our series (26.6%) compared with those in other series (7.9-17.3%) ( Table 6 ). In these patients, we accept the presence of some residual peripheral stones in the contralateral lobe after hepatectomy as our aim is to prevent recurrent stone formation, recurrent attacks of biliary sepsis and the occurrence of cholangiocarcinoma.
As we have shown, hepatectomy is safe for RPC and achieves the best possible results in terms of providing longterm relief of the disease; thus, we would recommend hepatectomy as the treatment of choice for RPC whenever possible. Indications for hepatectomy should be extended to patients with bilobar disease as residual stones in the less affected liver lobe may not cause subsequent clinical problems, as shown by our study. Cholecystectomy, exploration of the bile duct and drainage procedures alone may delay definitive treatment and make subsequent operative intervention difficult. Although percutaneous choledochoscopy was shown to have a satisfactory stone clearance rate of 85.3% in one large series of 245 patients, the overall rate for stone recurrence and/or cholangitis was 63.2% after a mean follow-up of 10.3 years. 17 The same group showed a similar result even when percutaneous choledochoscopy was used as the primary treatment for hepatolithiasis. 18 In another study that compared hepatectomy with percutaneous choledochoscopy for hepatolithiasis, both treatments were found to result in satisfactory rates of stone clearance, but stone recurrence in the percutaneous choledochoscopy group was much higher than in the hepatectomy group (31.5% vs. 5.6%). 19 Thus percutaneous choledochoscopy cannot be recommended as a definitive treatment in low-risk patients.
Conclusions
Hepatectomy is safe and yields the best treatment outcome for patients with RPC. Hepatectomy is desirable in the presence of atrophic liver segment or lobe, segment-or lobe-dominant disease, and in cases of suspected cholangiocarcinoma. The anticipation of incomplete stone clearance should not represent an obstacle to hepatectomy because incomplete clearance may not translate into a clinical problem. Drainage procedures alone and percutaneous choledochoscopy have high incidences of residual stone, stone recurrence and biliary sepsis recurrence. However, these procedures may be useful in the treatment of frail, elderly patients, and in those with complicated disease or previous hepatectomy.
